Panadol Sinus Relief (Phenylephrine Hydrochloride, Paracetamol, Caffeine)

Phenylephrine Hydrochloride, the active ingredient in Panadol Sinus Relief, is a decongestant presented as a tablet for oral use. It relieves nasal congestion associated with colds, sinusitis and seasonal allergies. Paracetamol and caffeine are included to provide analgesic and stimulant effects, supporting symptom relief in adults.

GNH USA supplies Panadol Sinus Relief as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panadol Sinus Relief combines three active ingredients that act on pain, inflammation and nasal congestion pathways. - Common cold: helps reduce headache, fever and sinus pressure associated with viral upper respiratory infections. - Sinusitis: alleviates sinus pain and pressure while improving nasal airflow. - Seasonal allergic rhinitis: eases nasal congestion and associated facial pain.

Side effects reported with Panadol Sinus Relief are generally mild and dose‑dependent.

Common Side Effects: - Dry mouth: mild dryness of the oral cavity. - Insomnia: difficulty falling or staying asleep. - Nausea: mild stomach upset. - Tremor: slight shaking of hands or limbs. - Increased heart rate: mild palpitations. - Headache: transient head discomfort.

Serious or Rare Side Effects: - Severe hypertension: marked rise in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Liver injury: elevated liver enzymes or jaundice. - Seizures: convulsive episodes, particularly in overdose. - Anaphylaxis: life‑threatening systemic allergic response.

When considering Panadol Sinus Relief, several safety points should be reviewed. - Cardiovascular disease: avoid if uncontrolled hypertension or recent heart attack. - Liver impairment: use with caution in patients with known hepatic dysfunction. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: review concomitant medications for potential additive effects. - Age restrictions: not recommended for children under 12 years without medical advice. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Panadol Sinus Relief may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Anticoagulants (e.g., warfarin): increased bleeding risk from paracetamol. - Beta‑blockers: may blunt the decongestant effect of phenylephrine.

Moderate Interactions (Monitor Closely): - Other stimulants (e.g., pseudo‑ephedrine): additive cardiovascular stimulation. - CYP1A2 substrates (e.g., theophylline): caffeine may increase plasma levels. - Diuretics: enhanced risk of electrolyte imbalance.